Status:
COMPLETED
Transcranial Magnetic Stimulation and Tobacco Use Disorder
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Conditions:
Tobacco Use Disorder
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if brain stimulation using repetitive transcranial magnetic stimulation (rTMS) directed at different parts of the brain can decrease feelings of cigarette cra...
Detailed Description
After the initial telephone screening, potentially eligible candidates will meet with staff and receive a lay-language explanation of the study. Candidates will review, ask about, and sign the informe...
Eligibility Criteria
Inclusion
- 18-45 years old
- Self-identified as male or female
- English fluency;
- Generally good health without cardiovascular, hepatic, renal, or autoimmune diseases; diabetes; or cancer
- Must have smoked for 1 year; smoke 10 cigarettes per day
- Meeting DSM 5 criteria for Tobacco Use Disorder
Exclusion
- Seeking treatment for nicotine dependence now or within 3 months before study entry
- A medical condition that may compromise safety
- A neurological disorder that would compromise compliance and/or informed consent
- A major psychiatric disorder
- Current drug use disorders other than Tobacco Use Disorder as defined by DSM 5
- Recent use of drugs of abuse as shown by urine test at the screening or testing sessions
- Smoke marijuana more than once a week
- Use of tobacco in forms other than cigarettes more than 10 days in last month
- Preference for menthol
- Pregnancy or nursing
- Seizure disorder
- Metal implants
- Any other circumstance that the investigators determine would compromise safety
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 19 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03827265
Start Date
February 1 2019
End Date
August 19 2024
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Semel Institute of Neuroscience
Los Angeles, California, United States, 90024